1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends

Biopharmaceutical CMO & CRO Market Analysis By Source, By Service Type, By Product And Segment Forecasts, 2014 - 2025

  • July 2017
  • 210 pages
  • Grand View Research
Report ID: 5068570

Summary

Table of Contents

Biopharmaceutical CMO & CRO Market Analysis By Source (Mammalian, Non-mammalian), By Service Type (Contract Manufacturing, Contract Research), By Product, And Segment Forecasts, 2014 - 2025

The global biopharmaceutical CMO & CRO (contract manufacturing & research) market is expected to reach USD 37.8 billion by 2025, according to a new report by Grand View Research, Inc.

Healthy outlook of biopharmaceuticals and consequent growth in biopharmaceutical pipelines has resulted into lack of adequate capacity and budget constraints. These factors have convinced many traditional drug developers to take advantage of cost-saving benefits associated with contract services. Traditional biopharmaceutical players are observed to choose outsourcing biopharmaceutical manufacturing rather than making an investment of expensive capital in production equipment and hiring skilled labor.
Significant improvement in the services offered by this CMOs/CROs in context to maturity of complex technology is spurring the adoption of these services. In addition, wide acceptance of single-use technology within CMOs/CROs has significantly transformed the CMOs/CROs landscape by enhancing their capabilities and enabling them to develop products at low operating costs.
Outsourcing services are observed to play critical role in overcoming trade barriers for firms. It enables them to make footprints in foreign market where government regulates to secure local employment through domestic production. Furthermore, as a result of growing demand for these services, smaller companies have also begun to expand their non-GMP facilities.

Further key findings from the report suggest:
• Mammalian cell line-based bioproduction system dominated the share in 2016 in terms of revenue generation
• This can be attributed to the presence of substantial number of mammalian-based manufacturing platforms offered by market leaders such as Lonza, Samsung BioLogics, WuXi Biologics
• CMOs are providing wide range of services for entire chain of biopharmaceutical manufacturing process, consequently held the largest share
• Growing R&D investment in bioproduction is the high impact rendering factor for the growth of CROs
• Robust biologics pipeline and high production cost of biologics have contributed to the largest share of biologics outsourcing
• Monoclonal antibodies accounted for significant share in 2016 owing to the huge success rate of MAbs for disease treatment
• North America is home to large number of biopharmaceutical manufacturing entities, which in turn, have resulted into large share of this region
• Being a lower wage country, China and India are expected to be fastest growing regional market
• Several global companies are translocating their business to Asia Pacific owing to low manufacturing costs in Asian countries
• Boehringer Ingelheim GmbH, Lonza, Samsung BioLogics, Patheon, FUJIFILM Diosynth Biotechnologies U.S.A., Inc. are some of the major companies operating in this space

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 24h.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Biopharmaceutical Contract Manufacturing Market: Oncology Segment by Therapeutic Area to Dominate the Global Market Through 2027: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027

  • $ 5000
  • Industry report
  • September 2017
  • by Future Market Insight Global & Consulting Pvt Ltd

Future Market Insights presents a detailed forecast of the global biopharmaceutical contract manufacturing market in a new report titled “Biopharmaceutical Contract Manufacturing Market: Global Industry ...

Global Biopharmaceuticals Market

  • $ 4250
  • Industry report
  • July 2017
  • by Mordor Intelligence LLP

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the yea ...

Global Automation Market in Biopharmaceutical Industry 2017-2021

  • $ 3500
  • Industry report
  • September 2017
  • by Infiniti Research Limited

About Automation in Biopharmaceutical Industry The global biopharmaceutical industry is the most rapidly growing industry in the science and technology sector owing to increasing R&D investments in bi ...

Global Biosimilars Market

July 2017 $ 4250

ref:plp2017

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.